{"cdcTestId":"2013-0409","testcaseName":"#3 @ 9 yrs, 16 weeks - 1 days, female, gardasil","vaccineGroup":"HPV","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2011-08-20T00:00:00","patient":{"dob":"2002-05-01T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2011-04-30T00:00:00","vaccineName":"GARDASIL","cvx":"62","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-05-28T00:00:00","vaccineName":"GARDASIL","cvx":"62","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-08-20T00:00:00","vaccineName":"GARDASIL","cvx":"62","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2011-04-30T00:00:00","vaccineName":"GARDASIL","cvx":"62","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-05-28T00:00:00","vaccineName":"GARDASIL","cvx":"62","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-08-20T00:00:00","vaccineName":"GARDASIL","cvx":"62","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-15T08:07:20.047","generalDescription":"This test case describes when a child is administered a third dose of the HPV vaccine at 16 weeks - 1 day, after the first dose, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1).","changedInVersion":"2.1","reasonForChange":"v2.1 Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age."}